Non-redundant roles for Th17 and Th22 cells in multiple myeloma clinical correlates

被引:12
|
作者
Di Lullo, Giulia [1 ,2 ]
Marcatti, Magda [3 ]
Protti, Maria Pia [1 ,2 ]
机构
[1] Ist Sci San Raffaele, IRCCS, Tumor Immunol Unit, I-20132 Milan, Italy
[2] Ist Sci San Raffaele, IRCCS, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy
[3] Ist Sci San Raffaele, IRCCS, Hematol & Bone Marrow Transplantat Unit, I-20132 Milan, Italy
来源
ONCOIMMUNOLOGY | 2016年 / 5卷 / 04期
关键词
BM mesenchymal stromal cells; BM microenvironment; bone disease; disease prognosis; IL-13; IL-17; IL-22; multiple myeloma; Th17; cells; Th22; DENDRITIC CELLS; INTERLEUKIN; 22; BONE-DISEASE; IDENTIFICATION; SUBSET; T(H)17; MARROW; IMMUNE; IL-17;
D O I
10.1080/2162402X.2015.1093278
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We recently reported that in multiple myeloma increased Th22 cell frequencies correlate with poor prognosis. Here we show that within the same patients' cohort Th17 cells associate with bone disease and not with prognosis. Thus, we propose that Th22 and Th17 cells play non-redundant roles in multiple myeloma and constitute independent therapeutic targets.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders
    Marlen Vitales-Noyola
    Ana M. Ramos-Levi
    Rebeca Martínez-Hernández
    Ana Serrano-Somavilla
    Miguel Sampedro-Nuñez
    Roberto González-Amaro
    Mónica Marazuela
    Endocrine, 2017, 57 : 409 - 417
  • [22] Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders
    Vitales-Noyola, Marlen
    Ramos-Levi, Ana M.
    Martinez-Hernandez, Rebeca
    Serrano-Somavilla, Ana
    Sampedro-Nunez, Miguel
    Gonzalez-Amaro, Roberto
    Marazuela, Monica
    ENDOCRINE, 2017, 57 (03) : 409 - 417
  • [23] Increased Th22 cells are independently associated with Th17 cells in type 1 diabetes
    Xu, Xinyu
    Zheng, Shuai
    Yang, Fan
    Shi, Yun
    Gu, Yong
    Chen, Heng
    Zhang, Mei
    Yang, Tao
    ENDOCRINE, 2014, 46 (01) : 90 - 98
  • [24] B cells control lupus autoimmunity by inhibiting Th17 and promoting Th22 cells
    Ji Yang
    Xue Yang
    Luman Wang
    Ming Li
    Cell Death & Disease, 11
  • [25] Increased Th22 cells are independently associated with Th17 cells in type 1 diabetes
    Xinyu Xu
    Shuai Zheng
    Fan Yang
    Yun Shi
    Yong Gu
    Heng Chen
    Mei Zhang
    Tao Yang
    Endocrine, 2014, 46 : 90 - 98
  • [26] A non-redundant role for RORa in TH17 cell development and TH17-driven inflammatory disorders
    Solt, Laura A.
    Wang, Ran
    Amir, Mohammed
    Chaudhari, Sweena M.
    Campbell, Sean
    Bassette, Molly A.
    Kamenecka, Theodore M.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [27] Obesity Is Associated With a Distinctive Th17 and Th22 Lymphocyte Polarization
    Fabbrini, Elisa
    Cella, Marina
    McCartney, Stephen A.
    Finck, Brian
    Chen, Zhouji
    Abumrad, Nada
    Colonna, Marco
    Klein, Samuel
    OBESITY, 2011, 19 : S74 - S75
  • [28] Circulating Th22 cells, as well as Th17 cells, are elevated in patients with renal cell carcinoma
    Peng, Zhiguo
    Hu, Yu
    Ren, Juchao
    Yu, Nengwang
    Li, Zeyan
    Xu, Zhonghua
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (01): : 99 - 108
  • [29] Th17/Th22 Cells Mediate Breakthrough Graft-Versus-Host-Disease
    Furlan, Scott N.
    Tkachev, Victor
    Watkins, Ben
    Betz, Kayla
    Panoskaltsis-Mortari, Angela
    Blazar, Bruce R.
    Kean, Leslie
    BLOOD, 2015, 126 (23)
  • [30] TH17 and TH22 cells: A confusion of antimicrobial response with tissue inflammation versus protection
    Akdis, Muebeccel
    Palomares, Oscar
    van de Veen, Willem
    van Splunter, Marloes
    Akdis, Cezmi A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (06) : 1438 - 1449